Walker Bragman

Walker Bragman

Co-founder of the OptOut Media Foundation, journalist, JD, and occasional cartoonist.
May
07
A Week Of Violence

A Week Of Violence

The top stories for the week ending 5/7/23.
6 min read
Apr
30
Tucker Carlson Gone, Labor Organizing, and Reproductive Freedom Victories

Tucker Carlson Gone, Labor Organizing, and Reproductive Freedom Victories

Top stories for the week ending 4/30/2023
7 min read
Apr
24
OptOut Special: An Interview With Journalist Matt Binder On Twitter's Shake-Up

OptOut Special: An Interview With Journalist Matt Binder On Twitter's Shake-Up

A special interview with journalist Matt Binder about Elon Musk's latest moves with his social media platform.
12 min read
Apr
16
Silence of the Left, Long COVID, and More

Silence of the Left, Long COVID, and More

The top stories for the week ending April 16, 2023!
8 min read
Apr
10
Beyond Trump: Pandemic Medicaid Coverage Ends 🗞 Abortion Pill Banned 🗞 Clarence Thomas' Corruption

Beyond Trump: Pandemic Medicaid Coverage Ends 🗞 Abortion Pill Banned 🗞 Clarence Thomas' Corruption

The best of independent media.
7 min read
Mar
27
Peter Thiel’s Secretive Spending

Peter Thiel’s Secretive Spending

Tax records reveal that the Thiel Foundation gave to a shadowy rightwing fund in 2021.
6 min read
Mar
26
Criminal Charges for Trump, Calls for a New Civil Rights Bill, and a Big Week at OptOut

Criminal Charges for Trump, Calls for a New Civil Rights Bill, and a Big Week at OptOut

OptOut covers the top stories for the week of March 20-March 26!
6 min read
Mar
21
PODCAST: Evan Greer on Net Neutrality and Online Censorship

PODCAST: Evan Greer on Net Neutrality and Online Censorship

Fight for the Future Director Evan Greer talks about online censorship, net neutrality, the battle against disinformation, and punk rock.
1 min read
Mar
12
Bank Failures, COVID Crisis, and Hope For Yemen

Bank Failures, COVID Crisis, and Hope For Yemen

The top stories this week from OptOut participating outlets.
6 min read
Mar
10
Pfizer Spends Big on IP Lobbying With Billions on the Line

Pfizer Spends Big on IP Lobbying With Billions on the Line

The pharmaceutical giant spent big bucks amid key international negotiations last year to protect record earnings.
9 min read